iShares Neuroscience and Healthcare ETF (IBRN)

Assets	$4.71M
Expense Ratio	0.47%
PE Ratio	33.05
Shares Out	200,000
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Ratio	n/a
1-Year Return	n/a

Volume	299
Open	23.56
Previous Close	23.60
Day's Range	23.56 - 23.83
52-Week Low	22.98
52-Week High	27.43
Beta	1.57
Holdings	59
Inception Date	Aug 24, 2022

About IBRN

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.

• Asset Class: Equity
• Region: Global
• Stock Exchange: NYSEARCA
• Ticker Symbol: IBRN
• Issuer: BlackRock
• Index Tracked: NYSE FactSet Global Neuro Biopharma and MedTech Net

Top 10 Holdings

41.55% of assets

Name	Symbol	Weight
PTC Therapeutics, Inc.	PTCT	4.39%
Axonics, Inc.	AXNX	4.30%
Intra-Cellular Therapies, Inc.	ITCI	4.29%
Karuna Therapeutics, Inc.	KRTX	4.19%
ACADIA Pharmaceuticals Inc.	ACAD	4.16%
Biogen Inc.	BIIB	4.16%
Integra LifeSciences Holdings Corporation	IART	4.10%
Alkermes plc	ALKS	4.09%
Neurocrine Biosciences, Inc.	NBIX	3.98%
Catalyst Pharmaceuticals, Inc.	CPRX	3.90%